Ophthalmology

Retinal Vein Occlusion Illuminated by Fluorescein Angiogram

Practice-Changing Medicine

AI Predicts Outcomes & Treatment Frequency for Retinal Vein Occlusion

In patients treated for macular edema with intravitreal aflibercept, AI may provide insights into personalized treatments.
The cost over one year of ranibizumab PDS with refills pro re nata (PRN) versus the cost of real-world regimens of ranibizumab, aflibercept, and bevacizumab injections.

Advancing Science

Ranibizumab Port Delivery System: Is There a Cost Benefit?

Comparison study presents a model for investigating costs of intravitreal anti-VEGF injections vs. ranibizumab PDS for nAMD.
Chicago Skyline

Conferences & Events

Presenters at World Cornea Congress VIII and AAO 2022

NYU Langone Health experts joined international ophthalmology colleagues in Chicago, September 28-October 3.
Person’s Eye with Protruding Cornea

Advancing Science

An Innovative Collaboration Seeks to Evolve Understanding of Keratoconus

Early diagnosis, disease stabilization, risk factor awareness, and genetic studies offer hope for patients.
Doctor Using Microscope in Operating Room

Surgical Innovation

Navigating Evolving Options for Glaucoma Surgery

A researcher of new, less-invasive technologies explains that all surgical options still play valuable roles.
Baby Boy Lying in Hospital Incubator

Practice-Changing Medicine

Better Predicting Progression of Retinopathy of Prematurity

An expert in ROP discusses opportunities to fix the gaps in detection and diagnosis.
Load More